Research progress on treatment of liver cirrhosis induced by hepatitis C / 中华临床感染病杂志
Chinese Journal of Clinical Infectious Diseases
;
(6): 85-88, 2014.
Article
in Chinese
| WPRIM
| ID: wpr-444915
ABSTRACT
Pegylated interferon plus ribavirin is still the standard treatment for hepatitis C,but the efficacy is often restricted by adverse events.HCV genotypes,viral dynamics during early treatment and gene polymorphism may be useful in predicting the efficacy of antiviral treatment.Several strategies have emerged to improve outcomes including low accelerating dose regimen (LADR) and prevention of complications.Direct antiviral drugs have been already used for HCV genotype 1 patients,and demonstrated improved efficacy.Besides,inhibitors and vitamin D may also be applied in antiviral therapy to improve the efficacy.This article reviews efficacy predictors,standard therapy,strategies and research on new medicaments in antiviral treatment of hepatitis C.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Prognostic study
Language:
Chinese
Journal:
Chinese Journal of Clinical Infectious Diseases
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS